@_backtableONC

A multidisciplinary podcast for healthcare professionals who provide cancer care!

 San Diego, CA
backtable.com/shows/tumor-board
Joined November 2024
  • Tweets316
  • Following732
  • Followers292
Always a pleasure!! 🙌🏼
Ronan Hsieh, MD, MS@ronanhsiehOct 22
Really excited to share a podcast I recorded with @Kate_Baker_MD @geoffreybuckle for HER2-amplified gastroesophageal cancer! What makes it even more exciting is that a great new therapy mentioned in this podcast, tislelizumab + zanidatamab + chemotherapy, has now been approved by FDA as a first-line therapy. Given zanidatmab was shown to be superior to trastuzumab in this study, I'd use this new regimen for almost all 1L HER2-amplified advanced GEA. Thanks @_backtableONC @AaronFrittsMD @jgong15 for invitation. It was a fun weekend at San Diego! @DaniCastilloMD @Ahn_Daniel_Onc @IbrahimSahinMD1 #HERIZON
1
6
174
Dr. Lindsay Peterson asks neuro-oncologist @barbaraobrienmd how common are brain mets in breast ca, and how has the prognosis changed in the last 5 years? @MDAndersonnews @SitemanCenter @WashUOncology Full episode here👉backtable.com/shows/tumor-bo…
3
191
When is less actually more with immunotherapy for metastatic colorectal cancer? Dr. Cathy Eng (@CathyEngMD) and Dr. Jun Gong (@jgong15) share how patient frailty, BRAF status, and the latest trial data shape their first-line decisions for MSI-high disease. Access the full episode in the BackTable app: backtable.com/shows/tumor-bo… This podcast is supported by Bristol Myers Squibb. #ONC75 #ColorectalCancer #Immunotherapy #mCRC #ClinicalTrial @Kate_Baker_MD @VUMCDiscoveries @CedarsSinai
1
3
274
What does extended follow-up reveal about dual immunotherapy in colorectal cancer? Dr. Cathy Eng (@CathyEngMD) and Dr. Jun Gong (@jgong15) discuss survival rates, maintenance strategies, and what these results mean for real-world patient counseling and expectations. Access the full episode in the BackTable app: backtable.com/shows/tumor-bo… This podcast is supported by Bristol Myers Squibb. #ONC75 #ColorectalCancer #Immunotherapy #ClinicalTrial #CheckMate8HW @Kate_Baker_MD @VUMCDiscoveries @CedarsSinai
8
5
551
How is dual immunotherapy rewriting the treatment algorithm for MSI-high metastatic colorectal cancer? Dr. Cathy Eng (@CathyEngMD) and Dr. Jun Gong (@jgong15) break down the CheckMate 8HW trial, the striking progression-free survival gains, and why combination regimens may give more patients a real shot at complete response. Access the full episode in the BackTable app: backtable.com/shows/tumor-bo… This podcast is supported by Bristol Myers Squibb. #ONC75 #ColorectalCancer #Immunotherapy #ClinicalTrial #CheckMate8HW @Kate_Baker_MD @VUMCDiscoveries @CedarsSinai
1
4
289
Another BackTable studio recording: Role of APPs in the Management of Pediatric Cancer Patients with @StJude faculty Sara Helming, Sara Meehan and Megan Murphy (coming soon!) #medEd #stjuderesearch
1
1
4
377
What guides real-world decisions when NETs outgrow somatostatin analogs? Dr. Chih-Yi Liao and Dr. Robert Ramirez break down the art of sequencing chemo, PRRT, and targeted therapies, all shaped by tumor burden, patient goals, and a multidisciplinary team. Watch the full episode here: backtable.com/shows/tumor-bo… This podcast is supported by Novartis. #ONC74 #Cancer #NET #PancreaticCancer #PRRT #SSA @Kate_Baker_MD @VUMCDiscoveries @UChicagoMed @OchsnerHealth
1
127
In-studio MultiD discussion covering IFS in pediatric head and neck cancer with Rob Tuliszewski, Dennis Juo @javan_nationMD @AnthonySheyn Leidy Tovar. Shout out to the @StJude docs for making the trip out to San Diego!! Episodes coming soon 😎 @radychildrens #medEd
2
1
5
527
Happening now in our San Diego studio! @AnthonySheyn and Dr. Sara Helmig discussing MultiD Management of Pediatric Head and Neck Malignancies 🔥🔥👏🎬
4
1
9
681
When is upfront PRRT the right call for advanced neuroendocrine tumors? Dr. Chih-Yi Liao and Dr. Robert Ramirez unpack patient selection, the real-world risks of peptide receptor radionuclide therapy (PRRT), and why somatostatin analogues (SSA) frequency bumps are a last resort for tough cases. Watch the full episode here: backtable.com/shows/tumor-bo… This podcast is supported by Novartis. #ONC74 #Cancer #NET #PancreaticCancer #PRRT #SSA @Kate_Baker_MD @VUMCDiscoveries @UChicagoMed @OchsnerHealth @OchsnerHemOnc
1
150
Load more